Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05995080
Other study ID # 0009-0009-3168-4445
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2022
Est. completion date May 1, 2024

Study information

Verified date August 2023
Source Istanbul Medeniyet University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Catheter-related bloodstream infections are associated with increased mortality, morbidity, and length of hospital stay. The incidence has decreased significantly with the strict implementation of preventive bundle cares and checklists in intensive care units. Bathing with solutions containing chlorhexidine has been included in preventive strategies in recent years. Although some studies have shown that chlorhexidine bathing reduces the frequency of hospital-associated infections, there are important differences in management of practice and adherence to practice in different facilities. The majority of the studies conducted include adult patients. According to the CDC guidelines, chlorhexidine bathing is recommended for children over 2 months of age to prevent catheter-related bloodstream infection. The aim of this study is to investigate the effect of daily bathing with 2% chlorhexidine gluconate solution in preventing catheter-related bloodstream infections in pediatric patients with temporary central venous catheters.


Description:

In patients with a central catheter for longer than 48 hours, the diagnosis of bloodstream infection will be recorded as laboratory-confirmed bloodstream infections according to CDC diagnostic criteria. Microorganisms detected in cultures will be classified as gram-positive and gram-negative or fungal agents. Infection with the resistant microorganism will be compared with the control group. Catheter colonization; be defined as bacterial growth of more than 15 colonies in the semiquantitative culture or 1000 colonies in the quantitative culture of the catheter segment or hub without clinical symptoms. Patients in both groups with a central catheter for longer than 48 hours will be treated with a standard bath every 72 hours. In addition to the control group, patients in the study group will be treated daily with 2% chlorhexidine gluconate, and the patients in these two groups will be compared in terms of catheter-related bloodstream infections and catheter colonization.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 1, 2024
Est. primary completion date May 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Months to 18 Years
Eligibility Inclusion Criteria: - Patients between the ages of 2 months and 18 years who had a temporary central venous catheter - Patients whose follow-up is continued for at least 48 hours with a central venous catheter Exclusion Criteria: - Patients younger than 2 months of age - Patients with a intensive care unit stay shorter than 48 hours - Immunosuppressive patients - Patients with a history of allergic reaction to chlorhexidine - Patients with skin lesions that interfere with skin cleansing with chlorhexidine - Patients whose family did not give consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
clorhexidine gluconate bathing
daily skin cleansing with chlorhexidine gluconate

Locations

Country Name City State
Turkey IMU Istanbul Kadiköy

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Medeniyet University

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Tien KL, Sheng WH, Shieh SC, Hung YP, Tien HF, Chen YH, Chien LJ, Wang JT, Fang CT, Chen YC. Chlorhexidine Bathing to Prevent Central Line-Associated Bloodstream Infections in Hematology Units: A Prospective, Controlled Cohort Study. Clin Infect Dis. 2020 — View Citation

Zerr DM, Milstone AM, Dvorak CC, Adler AL, Chen L, Villaluna D, Dang H, Qin X, Addetia A, Yu LC, Conway Keller M, Esbenshade AJ, August KJ, Fisher BT, Sung L. Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem c — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Catheter-related blood stream infection rates In patients with a central catheter for longer than 48 hours, the diagnosis of bloodstream infection will be recorded as laboratory-confirmed bloodstream infections according to CDC diagnostic criteria.
Microorganisms detected in cultures will be classified as gram-positive and gram-negative or fungal agents. Infection with the resistant microorganism will be compared with the control group.
2 years.
Primary Catheter colonization rates Catheter colonization; be defined as bacterial growth of more than 15 colonies in the semiquantitative culture or 1000 colonies in the quantitative culture of the catheter segment or hub without clinical symptoms. 2 years.
Primary Demographic features of participants The investigators will be evaluating the features below:
Age of the patients (months)
Sex of patients
Weight of patients (kilograms)
Height of patiens (centimeters)
2 years.
Primary Comorbidities of participants The investigators will be evaluating the comorbidities in each groups, in order to determine if any of these conditions would interfere with infection rates. 2 years.
Primary Catheter site of placement It will be classified as; femoral, internal jugular, subclavian. 2 years.
Primary The duration of intensive care unit stay for each participants It will be evaluated as days. 2 years.
Primary Duration of catheter usage It will be evaluated as the total amount of time as days. 2 years.
Primary Number of catheter lumens It will be evaluated wether it has 2 or 3 lumens. 2 years.
Primary Time when catheter is started the use It will be noted that the time of intensive care hospitalization that catheter usage started.
It will be evaluated as days.
2 years.
Primary Number of catheter dressing changes It will be evaluated that the amount of planned or unplanned changes of catheter dressing. 2 years.
Primary Reason for the catheter removal It will be classified as for example; infection, dysfunction, lack of need... 2 years.
Primary The reason of intensive care hospitalization for each participants It will be evaluated that the primary reason that cause for patient to need for intensive care. 2 years.
Primary PRISM (pediatric risk of mortality) score of the participants The Pediatric Risk of Mortality (PRISM) score was developed from the Physiologic Stability Index (PSI) to reduce the number of physiologic variables required for pediatric ICU (PICU) mortality risk assessment and to obtain an objective weighting of the remaining variables. 2 years.
Primary Need for invasive mechanical ventilation support It will be evaluated if the patient needed for invasive mechanical ventilation support or not. If so, how many days is it required will be noted. 2 years.
Primary Need for hemodialysis catheter usage It will be noted that wether the patient has hemodialysis catheter or not. 2 years.
Primary Presence of parenteral steroid use It will be noted that if during the intensive unit care, wether patient need pulse steroid treatment (30milligram/kilogram/day for 3 or more days) or treatment with Prednisolone 2 milligram/kilogram/day or more for 14 or more days 2 years.
Secondary Rate of catheter-related bloodstream infection in patients bathing with 2% chlorhexidine gluconate daily. Incidence will be determined by dividing the number of patients who had catheter-related bloodstream infections in patients who underwent daily skin cleansing with chlorhexidine, compared to the total number of patients who underwent daily skin cleansing with chlorhexidine.
Patients who were treated with a standard bath and those treated with a chlorhexidine bath will be compared.
Through study completion, 2 years.
Secondary Rate of catheter colonization in patients bathing with 2% chlorhexidine gluconate daily. Incidence will be determined by dividing the number of patients who had catheter colonization in patients who underwent daily skin cleansing with chlorhexidine, compared to the total number of patients who underwent daily skin cleansing with chlorhexidine.
Patients who were treated with a standard bath and those treated with a chlorhexidine bath will be compared.
2 years.
Secondary Microorganisms that grown in cultures of catheter-related bloodstream infection in patients bathing with 2% chlorhexidine gluconate daily. It will be noted which microorganisms grown in the cultures. By classifying microorganisms grown in culture (gram positive, gram negative, fungal infections, etc.), a comparison will be made between the two groups in terms of incidence. 2 years.
Secondary Microorganisms that cause catheter colonization in patients bathing with 2% chlorhexidine gluconate daily. It will also be noted which microorganisms grown in the cultures. By classifying microorganisms grown in culture (gram positive, gram negative, fungal infections, etc.), a comparison will be made between the two groups in terms of incidence. 2 years.
Secondary Rate of catheter-related bloodstream infection in patients who applied standard bathing Incidence will be determined by dividing the number of patients who had catheter-related bloodstream infection in patients who underwent standard bathing to the total number of patients who underwent standard bathing.
Patients who were treated with a standard bath and those treated with a chlorhexidine bath will be compared.
2 years
Secondary Rate of catheter colonizsation in patients who applied standard bathing Incidence will be determined by dividing the number of patients who had catheter colonization in patients who underwent standard bathing to the total number of patients who underwent standard bathing.
Patients who were treated with a standard bath and those treated with a chlorhexidine bath will be compared.
2 years
Secondary Microorganisms that grown in cultures of catheter-related bloodstream infection in patients which applied standard bathing It will also be noted which microorganisms grown in the cultures. By classifying microorganisms grown in culture (gram positive, gram negative, fungal infections, etc.), a comparison will be made between the two groups in terms of incidence. 2 years.
Secondary Microorganisms that cause catheter colonization in patients which applied standard bathing It will also be noted which microorganisms grown in the cultures. By classifying microorganisms grown in culture (gram positive, gram negative, fungal infections, etc.), a comparison will be made between the two groups in terms of incidence. 2 years.
See also
  Status Clinical Trial Phase
Terminated NCT04787926 - DuraLock-C Catheter Lock Solution
Active, not recruiting NCT02515201 - Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children Phase 4
Recruiting NCT04140916 - Comparison of Two Peripheral Inserted Intravenous Catheters N/A
Not yet recruiting NCT06019897 - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Completed NCT02970409 - Heparin Versus Saline in Peripheral Venous Catheter N/A
Completed NCT03101371 - Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion Phase 2
Completed NCT04821193 - Comparison of the Effects of 5%NaHCO3, 2%CHG and 70%Alcohol in the Prevention of Infections Related to Catheter N/A
Completed NCT04155723 - Impact of a Task Delegation to ICU Nurses for Midlines' Placement
Completed NCT02577718 - Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution Phase 1/Phase 2
Completed NCT02279121 - ATAPAC Study (TauroLock Activity in Adult Cancer Patients) N/A
Completed NCT00965198 - Comparison of Infection Rates Among Patients Using Two Catheter Access Devices N/A
Recruiting NCT05741866 - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) N/A
Recruiting NCT04825314 - Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization N/A
Active, not recruiting NCT03945045 - A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD N/A
Active, not recruiting NCT01592032 - Concentration of Antimicrobials in Catheter-lock Solutions Phase 4
Terminated NCT04906512 - Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy N/A
Withdrawn NCT02899780 - Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light N/A
Completed NCT04794231 - Comparison of Chlorhexidine Impregnated Dressing and Standard Dressing N/A
Terminated NCT03447639 - Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal Phase 4
Completed NCT03950921 - Pilot Testing a Patient Safety Display in the Hospital Setting N/A